Page last updated: 2024-10-31

molsidomine and Attention Deficit Disorder with Hyperactivity

molsidomine has been researched along with Attention Deficit Disorder with Hyperactivity in 1 studies

Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.

Attention Deficit Disorder with Hyperactivity: A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gao, Y1
Heldt, SA1

Other Studies

1 other study available for molsidomine and Attention Deficit Disorder with Hyperactivity

ArticleYear
Lack of neuronal nitric oxide synthase results in attention deficit hyperactivity disorder-like behaviors in mice.
    Behavioral neuroscience, 2015, Volume: 129, Issue:1

    Topics: Animals; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Disease Models, Animal;

2015